← back to search

Karim Khader

University of Utah · US
Area of research
Infectious Diseases · Applied Microbiology and Biotechnology
Research interest
Research interests include Antibiotic Use and Resistance, Clostridium difficile and Clostridium perfringens research, Antimicrobial Resistance in Staphylococcus, and Infection Control in Healthcare.
h-index
19
citations
1,994
works
103
NIH funding
primary concept
email

Recent publications

Trends in infection incidence and antimicrobial resistance in the US Veterans Affairs Healthcare System: a nationwide retrospective cohort study (2007–22)
The Lancet Infectious Diseases 2024cited by 13position: middledoi
Examining the clinical impact of rapid multiplex polymerase chain <scp>reaction‐based</scp> diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2022cited by 18position: middledoi
Association Between Contact Precautions and Transmission of Methicillin-Resistant <i>Staphylococcus aureus</i> in Veterans Affairs Hospitals
JAMA Network Open 2021cited by 28position: firstdoi
Incidence and Outcomes Associated With<i>Clostridium difficile</i>Infections
JAMA Network Open 2020cited by 135position: middledoi
Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source
JAMA Network Open 2020cited by 62position: middledoi
Effectiveness of Contact Precautions to Prevent Transmission of Methicillin-Resistant <i>Staphylococcus aureus</i> and Vancomycin-Resistant Enterococci in Intensive Care Units
Clinical Infectious Diseases 2020cited by 23position: firstdoi
Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci
Clinical Infectious Diseases 2019cited by 39position: middledoi
A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States
Antimicrobial Resistance and Infection Control 2018cited by 109position: middledoi
Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With <i>Clostridium difficile</i> Infection
JAMA Internal Medicine 2017cited by 159position: middledoi
Incidence of Extended-Spectrum β-Lactamase (ESBL)-Producing <i>Escherichia coli</i> and <i>Klebsiella</i> Infections in the United States: A Systematic Literature Review
Infection Control and Hospital Epidemiology 2017cited by 156position: middledoi
Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant <i>Staphylococcus Aureus</i>
Infection Control and Hospital Epidemiology 2017cited by 75position: middledoi
The Potential for Interventions in a Long-term Acute Care Hospital to Reduce Transmission of Carbapenem-Resistant Enterobacteriaceae in Affiliated Healthcare Facilities
Clinical Infectious Diseases 2017cited by 51position: middledoi
Incidence and Outcomes Associated With Infections Caused by Vancomycin-Resistant Enterococci in the United States: Systematic Literature Review and Meta-Analysis
Infection Control and Hospital Epidemiology 2016cited by 131position: middledoi
An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model
PLoS ONE 2016cited by 47position: middledoi
Costs and Mortality Associated With Multidrug-Resistant Healthcare-Associated <i>Acinetobacter</i> Infections
Infection Control and Hospital Epidemiology 2016cited by 44position: middledoi
Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities — United States
MMWR Morbidity and Mortality Weekly Report 2015cited by 160position: middledoi
The Magnitude of Time-Dependent Bias in the Estimation of Excess Length of Stay Attributable to Healthcare-Associated Infections
Infection Control and Hospital Epidemiology 2015cited by 51position: middledoi
Estimates of Outbreak Risk from New Introductions of Ebola with Immediate and Delayed Transmission Control
Emerging infectious diseases 2015cited by 18position: middledoi
Vital signs: improving antibiotic use among hospitalized patients.
PubMed 2014cited by 376position: middle
A Simulation-Based Assessment of Strategies to Control Clostridium Difficile Transmission and Infection
PLoS ONE 2013cited by 54position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Matthew H. Samore · University of Utah18 papers (2013–2024)Richard E. Nelson · University of Utah10 papers (2015–2020)Michael Rubin · Texas Tech University10 papers (2013–2019)Vanessa Stevens · United States Department of Veterans Affairs8 papers (2015–2021)Makoto Jones · United States Department of Veterans Affairs7 papers (2013–2021)Marin L. Schweizer · University of Iowa7 papers (2015–2020)Eli N. Perencevich · Open Society5 papers (2016–2020)Damon Toth · University of Utah5 papers (2013–2021)Amy Blevins · University of Iowa5 papers (2016–2020)John A. Jernigan · Centers for Disease Control and Prevention4 papers (2014–2017)Margaret L. Chorazy · University of Iowa4 papers (2016–2020)Hsiu‐Yin Chiang · University of Iowa4 papers (2016–2020)Rajeshwari Nair · University of Iowa4 papers (2016–2020)Rachel B. Slayton · University of Virginia4 papers (2014–2017)Melissa Ward · University of Iowa3 papers (2016–2020)Tristan T. Timbrook · Barnes-Jewish Hospital3 papers (2019–2022)Daniel J. Diekema · University of Colorado Denver2 papers (2017–2020)Jennifer S. McDanel · Improvement Service2 papers (2017–2020)Benedikt Huttner · World Health Organization - Pakistan2 papers (2013–2016)Alun Thomas · University of Utah2 papers (2020–2021)